BBI-355
Product Specifications
CAS Number
2871056-82-3
SKU
C02004-5mg
Target
Chk
Applications
Cell Cycle
Additionnal Information
BBI-355 is an oral, potent, and selective small molecule inhibitor of CHK1 with an IC50 of 0.3 nM. It demonstrates significant anti-tumor activity as a single agent and in combination with targeted therapies in multiple ecDNA+ oncogene amplified tumor models.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1387702-01 0.02 mg (E-Coli)
Recombinant Bordetella bronchiseptica UPF0271 protein BB4479 (BB4479)
Ask
View Details 
MBS1387702-02 0.1 mg (E-Coli)
Recombinant Bordetella bronchiseptica UPF0271 protein BB4479 (BB4479)
Ask
View Details MBS1387702-03 0.02 mg (Yeast)
Recombinant Bordetella bronchiseptica UPF0271 protein BB4479 (BB4479)
Ask
View Details MBS1387702-04 0.1 mg (Yeast)
Recombinant Bordetella bronchiseptica UPF0271 protein BB4479 (BB4479)
Ask
View Details MBS1387702-05 0.02 mg (Baculovirus)
Recombinant Bordetella bronchiseptica UPF0271 protein BB4479 (BB4479)
Ask
View Details